Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ajay Sharma, S"'
Publikováno v:
In Polyhedron 1 December 2020 192
Autor:
Binoy Kar, Shanooja Shanavas, Apoorva H. Nagendra, Utpal Das, Nilmadhab Roy, Sudhindra Pete, Ajay Sharma S, Sourav De, Ashok Kumar S K, Seshu Vardhan, Suban K. Sahoo, Debashis Panda, Sudheer Shenoy, Bipasha Bose, Priyankar Paira
Publikováno v:
Dalton Transactions. 51:5494-5514
GSH-resistant, hypoxia active iridium(iii)–Cp*-(imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenol complexes were developed as highly cytoselective anticancer agents and mitochondria-targeting CSC therapeutic agents.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf256b275319c6b3050083d1504b13d8
https://doi.org/10.1039/d2dt00168c
https://doi.org/10.1039/d2dt00168c
Publikováno v:
RSC Advances. 12:20264-20295
Metal complexes have gradually been attracting interest from researchers worldwide as potential cancer therapeutics. Driven by the many side effects of the popular platinum-based anticancer drug cisplatin, the tireless endeavours of researchers have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61639839a9b6477ef9f1e961201ed92e
https://doi.org/10.1039/d2ra03434d
https://doi.org/10.1039/d2ra03434d
Autor:
Sourav De, S. K. Ashok Kumar, Ajay Sharma S, Utpal Das, Nilmadhab Roy, Priyankar Paira, Sudhindra Pete, Binoy Kar, Debashis Panda
Publikováno v:
Dalton Transactions. 50:10369-10373
To avoid the side effects of the current popular platinum-based anticancer drugs, researchers have made tireless attempts to design appropriate GSH-resistant Ru(II)-arene complexes. In this regard, luminescent ruthenium(II)-p-cymene-imidazophenanthro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67cb205d101b5e31dc2f24b6171d1839
https://doi.org/10.1039/d1dt01604k
https://doi.org/10.1039/d1dt01604k
Autor:
Binoy, Kar, Shanooja, Shanavas, Apoorva H, Nagendra, Utpal, Das, Nilmadhab, Roy, Sudhindra, Pete, Ajay, Sharma S, Sourav, De, Ashok, Kumar S K, Seshu, Vardhan, Suban K, Sahoo, Debashis, Panda, Sudheer, Shenoy, Bipasha, Bose, Priyankar, Paira
Publikováno v:
Dalton transactions (Cambridge, England : 2003). 51(14)
Herein, we have introduced a series of iridium(III)-Cp*-(imidazo[4,5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c1e94253fc83c66c910a1f6755b782c3
https://pubmed.ncbi.nlm.nih.gov/35293923
https://pubmed.ncbi.nlm.nih.gov/35293923
Autor:
Binoy, Kar, Utpal, Das, Sourav, De, Sudhindra, Pete, Ajay, Sharma S, Nilmadhab, Roy, Ashok Kumar, S K, Debashis, Panda, Priyankar, Paira
Publikováno v:
Dalton transactions (Cambridge, England : 2003). 50(30)
To avoid the side effects of the current popular platinum-based anticancer drugs, researchers have made tireless attempts to design appropriate GSH-resistant Ru(ii)-arene complexes. In this regard, luminescent ruthenium(ii)-p-cymene-imidazophenanthro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::831921d33d057ec7b13f1704c3c464be
https://pubmed.ncbi.nlm.nih.gov/34308466
https://pubmed.ncbi.nlm.nih.gov/34308466
Publikováno v:
Inorganica Chimica Acta. 513:119925
The need to synthesize an effective anticancer drug with minimal side effects has been the aim and concern of the researchers around the world. Cytotoxicity and selectivity are the two important factors of an anticancer drug and the current clinicall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::415c6ad3e649e357ef86128bf93f31f5
https://doi.org/10.1016/j.ica.2020.119925
https://doi.org/10.1016/j.ica.2020.119925